NO20060786L - Farmasoytiske preparater med oppsvulmbart belegg - Google Patents
Farmasoytiske preparater med oppsvulmbart beleggInfo
- Publication number
- NO20060786L NO20060786L NO20060786A NO20060786A NO20060786L NO 20060786 L NO20060786 L NO 20060786L NO 20060786 A NO20060786 A NO 20060786A NO 20060786 A NO20060786 A NO 20060786A NO 20060786 L NO20060786 L NO 20060786L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- coating
- swelling coating
- surrounds
- active ingredient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2873—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN580CH2003 | 2003-07-17 | ||
IN1064CH2003 | 2003-12-30 | ||
US56370704P | 2004-04-20 | 2004-04-20 | |
PCT/US2004/022910 WO2005009410A2 (fr) | 2003-07-17 | 2004-07-16 | Compositions pharmaceutiques a revetement gonflant |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20060786L true NO20060786L (no) | 2006-04-10 |
Family
ID=34108415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20060786A NO20060786L (no) | 2003-07-17 | 2006-02-17 | Farmasoytiske preparater med oppsvulmbart belegg |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1651193A2 (fr) |
JP (1) | JP2007524646A (fr) |
KR (1) | KR20060065632A (fr) |
AU (1) | AU2004259226B2 (fr) |
BR (1) | BRPI0412697A (fr) |
CA (1) | CA2532310A1 (fr) |
HR (1) | HRP20060016A2 (fr) |
IL (1) | IL173053A0 (fr) |
MX (1) | MXPA06000577A (fr) |
NO (1) | NO20060786L (fr) |
NZ (1) | NZ544608A (fr) |
WO (1) | WO2005009410A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050147663A1 (en) * | 2003-07-17 | 2005-07-07 | Mohan Mailatur S. | Method of treatment for improved bioavailability |
FR2878159B1 (fr) * | 2004-11-24 | 2008-10-17 | Flamel Technologies Sa | Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire |
CA2608444A1 (fr) * | 2005-05-13 | 2007-03-15 | Combino Pharm, S.L. | Formulations contenant de l acide libre de pantoprazole et les sels de ce dernier |
CA2614526A1 (fr) * | 2005-07-11 | 2006-10-12 | Nycomed Danmark Aps | Formulation de benzimidazole |
WO2007080601A1 (fr) * | 2006-01-16 | 2007-07-19 | Jubilant Organosys Limited | Formulation pharmaceutique stable d'un compose labile a base d'acide et son procede de preparation |
EA021792B1 (ru) | 2008-03-11 | 2015-09-30 | Такеда Фармасьютикал Компани Лимитед | Твердый препарат, растворяющийся во рту |
EP2319504A1 (fr) * | 2009-11-07 | 2011-05-11 | Laboratorios Del. Dr. Esteve, S.A. | Forme pharmaceutique solide |
US20130216617A1 (en) * | 2010-06-29 | 2013-08-22 | Cadila Healthcare Limited | Pharmaceutical compositions of (r)-lansoprazole |
EP2950790A4 (fr) | 2012-08-09 | 2018-04-25 | Dynamis Therapeutics, Inc. | Méthodes destinées à préserver ou à améliorer la santé, le bien-être et/ou une fonction physiologique chez un sujet |
JP6856326B2 (ja) * | 2016-07-15 | 2021-04-07 | 富士化学工業株式会社 | 腸放出粒子組成物 |
KR101907116B1 (ko) | 2016-07-25 | 2018-10-11 | 한미약품 주식회사 | 에스오메프라졸, 또는 약학적으로 허용 가능한 그의 염을 포함하는, pH-의존성 약물 방출 특성이 개선된 제형 |
KR101877350B1 (ko) * | 2016-10-28 | 2018-08-09 | 한미약품 주식회사 | 에스오메프라졸 함유 복합 캡슐제 및 그 제조방법 |
JP6336651B1 (ja) * | 2016-12-15 | 2018-06-06 | 大原薬品工業株式会社 | 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤 |
MX2020001760A (es) * | 2017-09-28 | 2020-07-29 | Hanmi Pharm Ind Co Ltd | Composicion farmaceutica que incluye un comprimido esferoide de multiples unidades que contiene esomeprazol y una sal farmaceuticamente aceptable esferoide de este, y metodo para preparar la composicion farmaceutica. |
JP7026510B2 (ja) * | 2018-01-11 | 2022-02-28 | 株式会社Screenホールディングス | 印刷物、読取装置、読取方法、印刷方法、および印刷装置 |
CN111728124A (zh) * | 2020-07-08 | 2020-10-02 | 江苏宏远药业有限公司 | 一种安全性较高的食品级白色素 |
CN115998705A (zh) * | 2022-08-26 | 2023-04-25 | 苏州弘森药业股份有限公司 | 一种非布司他纳米包合物的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US341338A (en) * | 1886-05-04 | Blind | ||
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
YU48263B (sh) * | 1991-06-17 | 1997-09-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh. | Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola |
US5882715A (en) * | 1995-06-20 | 1999-03-16 | Pharma-Vinci A/S | Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
DE69631981T2 (de) * | 1995-09-21 | 2005-04-14 | Pharma Pass Ii Llc, Irvine | Lansoprazolhaltige Arzneizusammensetzung und Herstellungsverfahren |
US6296876B1 (en) * | 1997-10-06 | 2001-10-02 | Isa Odidi | Pharmaceutical formulations for acid labile substances |
US6500459B1 (en) * | 1999-07-21 | 2002-12-31 | Harinderpal Chhabra | Controlled onset and sustained release dosage forms and the preparation thereof |
US6635206B1 (en) * | 2000-05-03 | 2003-10-21 | The Board Of Trustees Of The University Of Illinois | Method of manufacturing improved corn zein resin films, sheets, and articles |
US6368628B1 (en) * | 2000-05-26 | 2002-04-09 | Pharma Pass Llc | Sustained release pharmaceutical composition free of food effect |
PE20050150A1 (es) * | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
-
2004
- 2004-07-16 KR KR1020067001095A patent/KR20060065632A/ko not_active Application Discontinuation
- 2004-07-16 MX MXPA06000577A patent/MXPA06000577A/es unknown
- 2004-07-16 JP JP2006520372A patent/JP2007524646A/ja not_active Withdrawn
- 2004-07-16 AU AU2004259226A patent/AU2004259226B2/en not_active Ceased
- 2004-07-16 NZ NZ544608A patent/NZ544608A/en unknown
- 2004-07-16 EP EP04778421A patent/EP1651193A2/fr not_active Withdrawn
- 2004-07-16 BR BRPI0412697-1A patent/BRPI0412697A/pt not_active IP Right Cessation
- 2004-07-16 WO PCT/US2004/022910 patent/WO2005009410A2/fr active Application Filing
- 2004-07-16 CA CA002532310A patent/CA2532310A1/fr not_active Abandoned
-
2006
- 2006-01-10 IL IL173053A patent/IL173053A0/en unknown
- 2006-01-12 HR HR20060016A patent/HRP20060016A2/hr not_active Application Discontinuation
- 2006-02-17 NO NO20060786A patent/NO20060786L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007524646A (ja) | 2007-08-30 |
CA2532310A1 (fr) | 2005-02-03 |
NZ544608A (en) | 2008-07-31 |
BRPI0412697A (pt) | 2006-10-03 |
EP1651193A2 (fr) | 2006-05-03 |
WO2005009410A2 (fr) | 2005-02-03 |
IL173053A0 (en) | 2006-06-11 |
KR20060065632A (ko) | 2006-06-14 |
MXPA06000577A (es) | 2006-07-03 |
HRP20060016A2 (en) | 2006-02-28 |
WO2005009410A3 (fr) | 2005-05-19 |
AU2004259226A1 (en) | 2005-02-03 |
AU2004259226B2 (en) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20060786L (no) | Farmasoytiske preparater med oppsvulmbart belegg | |
DK1191926T3 (da) | Ny omeprazol- og (S)-omeprazolformulering | |
NO20042161L (no) | Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1 | |
SE9704869D0 (sv) | New pharmaceutical formulaton II | |
MX2007006212A (es) | Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular. | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
NO20080164L (no) | N-(pyridin-2-yl)-sulfonamidderivater | |
TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
ECSP045102A (es) | Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo | |
PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
NO20030381L (no) | Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser | |
SE9500422D0 (sv) | New oral pharmaceutical dosage forms | |
ATE292453T1 (de) | Antivirale arznei | |
NO20055891L (no) | Kinazolinderivater som aurorakinaseinhibitorer | |
AR025001A1 (es) | Formulacion de sal comun y moxifloxacina | |
NO20040268L (no) | Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen | |
NO20060445L (no) | Fast farmasoytisk preparat omfattende amisulprid | |
NO20101070L (no) | Fremgangsmate til dosering av et medikament, samt doseringsform | |
NO20052408D0 (no) | Farmasoytisk formulering av olanzapin | |
PT1318792E (pt) | Composicao de libertacao prolongada que contem claritromicina | |
ATE260650T1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
EE200200283A (et) | Zolmitriptaani sisaldavad ravimpreparaadid | |
SE9700885D0 (sv) | New pharmaceutical formulation | |
RS50298B (sr) | Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina | |
ATE262893T1 (de) | Darreichungsformen zur behandlung von oralen mykosen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |